Cargando…

Evaluating waiting time with real-world health information in a high-volume cancer center

Wait time and scheduling for outpatient chemotherapy administration depends on various factors including infusion room hours of operation, availability of oncologists, nursing and pharmacy staffing, and physical space limitations. The aim of this study was to use the electronic event log of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyu-pyo, Park, Yu Rang, Lee, Jung Bok, Kim, Hae Reong, Lyu, Yongman, Kim, Jeong-Eun, Hong, Yong Sang, Lee, Jae-Lyun, Kim, Tae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523863/
https://www.ncbi.nlm.nih.gov/pubmed/32991401
http://dx.doi.org/10.1097/MD.0000000000021796
_version_ 1783588447398658048
author Kim, Kyu-pyo
Park, Yu Rang
Lee, Jung Bok
Kim, Hae Reong
Lyu, Yongman
Kim, Jeong-Eun
Hong, Yong Sang
Lee, Jae-Lyun
Kim, Tae Won
author_facet Kim, Kyu-pyo
Park, Yu Rang
Lee, Jung Bok
Kim, Hae Reong
Lyu, Yongman
Kim, Jeong-Eun
Hong, Yong Sang
Lee, Jae-Lyun
Kim, Tae Won
author_sort Kim, Kyu-pyo
collection PubMed
description Wait time and scheduling for outpatient chemotherapy administration depends on various factors including infusion room hours of operation, availability of oncologists, nursing and pharmacy staffing, and physical space limitations. The aim of this study was to use the electronic event log of patients on health information system (HIS) to map and analyze patient flow in advanced metastatic colorectal patients at an academic cancer center. From January 2009 to December 2014, patients who were diagnosed with metastatic colorectal cancer and received outpatient chemotherapy confined to FOLFIRI (fluorouracil, leucovorin, and irinotecan) or FOLFOX (folinic acid, fluorouracil, and oxaliplatin) were identified. From the HIS, patient flow was mapped by collection of event records including blood collection and pretreatment laboratory test, arrival to outpatient clinics, outpatient session (interview, drug accountability and appointment scheduling), and initiation of chemotherapy. A total of 10,638 patients were analyzed for 136,281 outpatient visits. The total office stay time from outpatient registration to initiation of chemotherapy was 92.58 ± 87.96 (mean ± standard deviation) minutes. Each outpatient session lasted 23.75 ± 51.55 minutes. After completing the outpatient session, patients waited 1,657.23 ± 3,027.65 minutes before chemotherapy and 46.66 ± 75.94 minutes within infusion room. Compared to the prior first come first serve rule, the new reservation system showed an improvement in overall waiting time from 2,432.3 ± 4,822.9 to 2,386.7 ± 143.4 minutes; however, waiting time within infusion room slightly increased from 36.68 ± 49.33 to 48.13 ± 46.32 minutes. Our findings indicate that transaction data analytics from HIS can be used to evaluate patient flow within oncology outpatient practice based on real-world hospital data.
format Online
Article
Text
id pubmed-7523863
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75238632020-10-14 Evaluating waiting time with real-world health information in a high-volume cancer center Kim, Kyu-pyo Park, Yu Rang Lee, Jung Bok Kim, Hae Reong Lyu, Yongman Kim, Jeong-Eun Hong, Yong Sang Lee, Jae-Lyun Kim, Tae Won Medicine (Baltimore) 5700 Wait time and scheduling for outpatient chemotherapy administration depends on various factors including infusion room hours of operation, availability of oncologists, nursing and pharmacy staffing, and physical space limitations. The aim of this study was to use the electronic event log of patients on health information system (HIS) to map and analyze patient flow in advanced metastatic colorectal patients at an academic cancer center. From January 2009 to December 2014, patients who were diagnosed with metastatic colorectal cancer and received outpatient chemotherapy confined to FOLFIRI (fluorouracil, leucovorin, and irinotecan) or FOLFOX (folinic acid, fluorouracil, and oxaliplatin) were identified. From the HIS, patient flow was mapped by collection of event records including blood collection and pretreatment laboratory test, arrival to outpatient clinics, outpatient session (interview, drug accountability and appointment scheduling), and initiation of chemotherapy. A total of 10,638 patients were analyzed for 136,281 outpatient visits. The total office stay time from outpatient registration to initiation of chemotherapy was 92.58 ± 87.96 (mean ± standard deviation) minutes. Each outpatient session lasted 23.75 ± 51.55 minutes. After completing the outpatient session, patients waited 1,657.23 ± 3,027.65 minutes before chemotherapy and 46.66 ± 75.94 minutes within infusion room. Compared to the prior first come first serve rule, the new reservation system showed an improvement in overall waiting time from 2,432.3 ± 4,822.9 to 2,386.7 ± 143.4 minutes; however, waiting time within infusion room slightly increased from 36.68 ± 49.33 to 48.13 ± 46.32 minutes. Our findings indicate that transaction data analytics from HIS can be used to evaluate patient flow within oncology outpatient practice based on real-world hospital data. Lippincott Williams & Wilkins 2020-09-25 /pmc/articles/PMC7523863/ /pubmed/32991401 http://dx.doi.org/10.1097/MD.0000000000021796 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5700
Kim, Kyu-pyo
Park, Yu Rang
Lee, Jung Bok
Kim, Hae Reong
Lyu, Yongman
Kim, Jeong-Eun
Hong, Yong Sang
Lee, Jae-Lyun
Kim, Tae Won
Evaluating waiting time with real-world health information in a high-volume cancer center
title Evaluating waiting time with real-world health information in a high-volume cancer center
title_full Evaluating waiting time with real-world health information in a high-volume cancer center
title_fullStr Evaluating waiting time with real-world health information in a high-volume cancer center
title_full_unstemmed Evaluating waiting time with real-world health information in a high-volume cancer center
title_short Evaluating waiting time with real-world health information in a high-volume cancer center
title_sort evaluating waiting time with real-world health information in a high-volume cancer center
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523863/
https://www.ncbi.nlm.nih.gov/pubmed/32991401
http://dx.doi.org/10.1097/MD.0000000000021796
work_keys_str_mv AT kimkyupyo evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT parkyurang evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT leejungbok evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT kimhaereong evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT lyuyongman evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT kimjeongeun evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT hongyongsang evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT leejaelyun evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter
AT kimtaewon evaluatingwaitingtimewithrealworldhealthinformationinahighvolumecancercenter